Augment Biologics
PrivateLast Round
Accelerator
Sep 2, 2025
Total Funding Raised
$350,000
Company Overview
Augment Biologics operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was an Accelerator round in September 2025.
Augment Biologics is a biotechnology company that develops an AI-powered platform for site-specific glycoprotein engineering to enhance the efficacy, safety, and durability of biologics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Augment Biologics Comparables
Compare Augment Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kyron.bio | 74% | |
| AbInitio Bio | 72% | |
| Chan Zuckerberg Biohub | 71% |
For institutional investors. Book with your work email.
Augment Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 2, 2025 | ||||
| Pre Seed | Aug 13, 2025 | ||||
| Accelerator | Dec 2, 2024 |
For institutional investors. Book with your work email.
Augment Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Northpond Ventures | Accelerator |
| McKesson Ventures | Accelerator |
| IndieBio | Pre Seed |
| Merck Digital Sciences Studio | Accelerator |
| New Jersey Innovation Institute | Accelerator |
| SOSV | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 2, 2025
Received funding from MassBio.
- Aug 13, 2025
$250K round led by SOSV
For institutional investors. Book with your work email.
Augment Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Augment Biologics's valuation, stock price, and market status.
Is Augment Biologics a public or private company?
Augment Biologics is a private company.
What is the current stock price of Augment Biologics?
Augment Biologics is a private company, so its shares have no public market price. Caplight tracks Augment Biologics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Augment Biologics worth (valuation)?
Valuation information for Augment Biologics is not publicly available.
Can I buy Augment Biologics stock?
Augment Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Augment Biologics's last funding round?
Augment Biologics's most recent funding round was Accelerator on September 2, 2025.
Who are the main investors in Augment Biologics?
Key investors in Augment Biologics include SOSV.
Will Augment Biologics IPO soon?
No public IPO plans have been announced for Augment Biologics.
How can I track Augment Biologics secondary market activity?
Caplight tracks bids, offers, and trades in Augment Biologics's shares on secondary markets.